SMAD3 and renal fibrosis: Our prior studies [14,16] have demonstrated that GAS5 inhibits renal fibrosis via microRNA-mediated pathways, including suppression of miR-21 activity and regulation of the Smad3/miRNA-142-5p axis in TGF-β signaling.